Marquez Elena 4

What Happened

• Elena Marquez, Chief Financial Officer of Anterix, was awarded a total of 21,147 shares on May 20, 2026: 3,694 restricted stock units (RSUs) and 17,453 derivative awards (option-type/vested shares). Both grants were reported as acquired at $0.00 (i.e., granted rather than purchased) and therefore show $0 cash outlay on the Form 4.

Key Details

• Transaction date: May 20, 2026; Form 4 filed May 22, 2026 (filed within the typical 2-business-day window).
• Grants: 3,694 RSUs (footnote F1) and 17,453 derivative awards/options (footnote F2); combined = 21,147 shares.
• Price: $0.00 per share (grant).
• Vesting: Both awards vest over three years — 1/3 on May 20, 2027, then 1/12 quarterly on Aug 10, Nov 10, Feb 10 and May 20 through May 20, 2029 (see footnotes).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Filing timeliness: Reported filed May 22 for a May 20 grant (appears timely).

Context

• RSUs represent a contingent right to receive shares as they vest; the RSU portion (3,694) does not become actual shares until vesting and delivery.
• The 17,453 derivative awards are subject to vesting (per F2) and are not immediately exercisable common stock; they will convert/become exercisable over the stated vesting schedule.
• Grants to executives are common compensation practice and do not, by themselves, signal buying or selling interest in the open market since they were awarded, not purchased or sold.